Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cella

Showing results (651-660 of 1,017) with videos related to

Pageof 102
Sort By:
The Lancet. Oncology|June 11, 2016
Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trialDavid Cella, Viktor Grünwald, Paul Nathan, et al.
Journal of Huntington'S Disease|October 3, 2017
Reliability and Validity of the HD-PRO-TriadTM, a Health-Related Quality of Life Measure Designed to Assess the Symptom Triad of Huntington's DiseaseNicholas R Boileau, Julie C Stout, Janes S Paulsen, et al.
Health Economics|September 5, 2019
U.K. utility weights for the EORTC QLU-C10DRichard Norman, Rebecca Mercieca-Bebber, Donna Rowen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 16, 2022
How do patients interpret and respond to a single-item global indicator of cancer treatment tolerability?John Devin Peipert, Sara Shaunfield, Karen Kaiser, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 24, 2023
Correction to: How do patients interpret and respond to a single‑item global indicator of cancer treatment tolerability?John Devin Peipert, Sara Shaunfield, Karen Kaiser, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 4, 2010
Validation of pediatric Functional Assessment of Cancer Therapy: patient version 2 of "brain tumor survivor" for grade school patients aged 7-12 yearsHeejung Yoo, Young-Shin Ra, Hyeon-Jin Park, et al.
Journal of Huntington'S Disease|August 20, 2019
Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington DiseaseNoelle E Carlozzi, Siera Goodnight, Anna L Kratz, et al.
Psychosomatics|September 27, 2016
Agitation, Delirium, and Cognitive Outcomes in Intracerebral HemorrhageLisa J Rosenthal, Brandon A Francis, Jennifer L Beaumont, et al.
Journal of Cancer Survivorship : Research and Practice|June 26, 2021
Association of cognitive impairment and breast cancer survivorship on quality of life in younger breast cancer survivorsDiane Von Ah, Adele D Crouch, Patrick O Monahan, et al.
Cancer|October 20, 2020
Self-reported physical activity, sitting time, and mental and physical health among older cancer survivors compared with adults without a history of cancerErika Rees-Punia, Alpa V Patel, Joseph R Nocera, et al.
Pageof 102

Showing results (651-660 of 1,017) with videos related to

Sort By:
Pageof 102
The Lancet. Oncology|June 11, 2016
Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trialDavid Cella, Viktor Grünwald, Paul Nathan, et al.
Journal of Huntington'S Disease|October 3, 2017
Reliability and Validity of the HD-PRO-TriadTM, a Health-Related Quality of Life Measure Designed to Assess the Symptom Triad of Huntington's DiseaseNicholas R Boileau, Julie C Stout, Janes S Paulsen, et al.
Health Economics|September 5, 2019
U.K. utility weights for the EORTC QLU-C10DRichard Norman, Rebecca Mercieca-Bebber, Donna Rowen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 16, 2022
How do patients interpret and respond to a single-item global indicator of cancer treatment tolerability?John Devin Peipert, Sara Shaunfield, Karen Kaiser, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 24, 2023
Correction to: How do patients interpret and respond to a single‑item global indicator of cancer treatment tolerability?John Devin Peipert, Sara Shaunfield, Karen Kaiser, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 4, 2010
Validation of pediatric Functional Assessment of Cancer Therapy: patient version 2 of "brain tumor survivor" for grade school patients aged 7-12 yearsHeejung Yoo, Young-Shin Ra, Hyeon-Jin Park, et al.
Journal of Huntington'S Disease|August 20, 2019
Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington DiseaseNoelle E Carlozzi, Siera Goodnight, Anna L Kratz, et al.
Psychosomatics|September 27, 2016
Agitation, Delirium, and Cognitive Outcomes in Intracerebral HemorrhageLisa J Rosenthal, Brandon A Francis, Jennifer L Beaumont, et al.
Journal of Cancer Survivorship : Research and Practice|June 26, 2021
Association of cognitive impairment and breast cancer survivorship on quality of life in younger breast cancer survivorsDiane Von Ah, Adele D Crouch, Patrick O Monahan, et al.
Cancer|October 20, 2020
Self-reported physical activity, sitting time, and mental and physical health among older cancer survivors compared with adults without a history of cancerErika Rees-Punia, Alpa V Patel, Joseph R Nocera, et al.
Pageof 102